Application of Artificial Intelligence Modeling Technology Based on Fluid Biopsy to Diagnose Alzheimer’s Disease

Background: There are no obvious clinical signs and symptoms in the early stages of Alzheimer’s disease (AD), and most patients usually have mild cognitive impairment (MCI) before diagnosis. Therefore, early diagnosis of AD is very critical. This paper mainly discusses the blood biomarkers of AD pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sh, Yuan, Liu, Benliang, Zhang, Jianhu, Zhou, Ying, Hu, Zhiyuan, Zhang, Xiuli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679840/
https://www.ncbi.nlm.nih.gov/pubmed/34924996
http://dx.doi.org/10.3389/fnagi.2021.768229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679840/
https://www.ncbi.nlm.nih.gov/pubmed/34924996
http://dx.doi.org/10.3389/fnagi.2021.768229

Ejemplares similares